TAG

Results for: OPINION

New act on Finnish health and social data provides opportunities for research and business

Finland is well-known for extensive, high-quality registries for health and social care data. Such data is important for many purposes, such as scientific research, drug and health technology development, and knowledge-based management, to mention just a few. A recently approved act on secondary use of health and social care data opens up new possibilities and… Read more »


Mastering modern medical affairs

Over the past 10 years, medical affairs has lifted its profile probably more than any other function in the pharmaceutical industry. Currently, medical affairs is considered by most companies to be a major strategic driver for business. The basis for this change is in the developing landscape of the industry. Some of the key trends… Read more »


What is your real-world data strategy?

The entire pharmaceutical industry is built on various forms of data and has recently invested substantial resources towards collecting and analyzing real-world data (RWD). RWD has traditionally been viewed as a tool to primarily support market access and demonstrate product value. But when such data is used beyond the traditional applications, throughout the product lifecycle… Read more »


CONTACT

MEDENGINE - BRIDGING
MEDICAL SCIENCE
WITH BUSINESS

GET IN TOUCH

029-1701101
info@medengine.fi

VISIT US

Eteläranta 14
00130 Helsinki
FINLAND


© 2019 MedEngine Oy